Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities

The emergence of drug resistance in cancer poses the greatest hurdle for successful therapeutic results and is associated with most cancer deaths. In triple negative breast cancer (TNBC), due to the lack of specific therapeutic targets, systemic chemotherapy is at the forefront of treatments, but it...

Descripción completa

Detalles Bibliográficos
Autores principales: Kordias, Dimitris, Kostara, Christina E., Papadaki, Styliani, Verigos, John, Bairaktari, Eleni, Magklara, Angeliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454761/
https://www.ncbi.nlm.nih.gov/pubmed/36078127
http://dx.doi.org/10.3390/cells11172719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454761/
https://www.ncbi.nlm.nih.gov/pubmed/36078127
http://dx.doi.org/10.3390/cells11172719

Ejemplares similares